These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20547555)

  • 1. Cross-reactivity of rabbit anti-bovine thrombin IgGs with human alpha-thrombin and a recombinant version of human thrombin (Recothrom).
    He Zhu ; Hoppensteadt D; Cunanan J; Fareed J
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):273-80. PubMed ID: 20547555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of various thrombin products with anti-rabbit antibodies to bovine, human, and recombinant thrombin.
    Sadeghi N; Zhu H; Setty SK; Cunanan J; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):243-8. PubMed ID: 22345489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of rabbit anti-bovine prothrombin/thrombin IgGs with bovine factor V/Va-related antigens.
    He Zhu ; Hoppensteadt D; Morris M; Fareed J
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):522-8. PubMed ID: 20699260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative purity of different bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Iqbal O; Litinas E; Adiguzel C; Fareed J
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):681-8. PubMed ID: 19850589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application.
    Zhu H; Hoppensteadt D; Wahi R; Cunanan J; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):32-40. PubMed ID: 18977777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunogenic potentials of bovine thrombin preparations.
    Zhu H; Hoppensteadt D; Adiguzel C; Bick RL; Fareed J
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):41-9. PubMed ID: 19117966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
    Rodgers GM
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and clinical significance of developing antibodies induced by topical thrombin preparations.
    Dorion RP; Hamati HF; Landis B; Frey C; Heydt D; Carey D
    Arch Pathol Lab Med; 1998 Oct; 122(10):887-94. PubMed ID: 9786349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
    Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
    Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of antibodies to the topical hemostat bovine thrombin.
    Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
    J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine thrombin: history, use, and risk in the surgical patient.
    Diesen DL; Lawson JH
    Vascular; 2008; 16 Suppl 1():S29-36. PubMed ID: 18544303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-BSA antibodies do not cross-react with the 69-kDa islet cell autoantigen ICA69.
    Rønningen KS; Atrazhev A; Luo L; Luo C; Smith DK; Korbutt G; Rajotte RV; Elliott JF
    J Autoimmun; 1998 Jun; 11(3):223-31. PubMed ID: 9693970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of Streptococcus mutans SR protein and human IgG cross-reactive determinants, by using recombinant proteins and synthetic peptides.
    Gangloff S; M'Zoughi R; Lett E; Scholler M; Baer J; Pini A; Ogier J; Klein JP
    J Immunol; 1992 May; 148(10):3249-55. PubMed ID: 1374451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
    Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
    J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative purity of thrombin-based hemostatic agents used in surgery.
    Schoenecker JG; Johnson RK; Fields RC; Lesher AP; Domzalski T; Baig K; Lawson JH; Parker W
    J Am Coll Surg; 2003 Oct; 197(4):580-90. PubMed ID: 14522327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic and antigenic epitopes of immunoglobulins I. Cross-reactivity of murine monoclonal antibodies to human IgG with the immunoglobulins of certain animal species.
    Jefferis R; Lowe J; Ling NR; Porter P; Senior S
    Immunology; 1982 Jan; 45(1):71-7. PubMed ID: 6173313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine hemoglobin (glutamer-250, Hemopure)-specific immunoglobulin G antibody cross-reacts with human hemoglobin but does not lyse red blood cells in vitro.
    Hamilton RG; Kickler TS
    Transfusion; 2007 Apr; 47(4):723-8. PubMed ID: 17381632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical safety of recombinant human thrombin.
    Heffernan JK; Ponce RA; Zuckerman LA; Volpone JP; Visich J; Giste EE; Jenkins N; Boster D; Pederson S; Knitter G; Palmer T; Wills M; Early RJ; Rogge MC
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):48-58. PubMed ID: 16971028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.